Product Name | MF | CAS | Details |
---|
Riociguat Impurity 17/6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one | C19H15FN8O | 1361569-18-7 | Details |
Riociguat Impurity 20/Isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate | C22H23FN8O2 | 625115-54-0 | Details |
Riociguat Impurity 19/N-Desmethyl Riociguat/Methyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate | C19H17FN8O2 | 625115-52-8 | Details |
Riociguat Impurity 22/(E)-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-5-(phenyldiazenyl)pyrimidine-4,6-diamine | C23H18FN9 | 428854-23-3 | Details |
Riociguat Impurity 30/2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine | C19H19FN8 | 1169770-52-8 | Details |
Riociguat Impurity 25/2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5- methylpyrimidine-4,5,6-triamine | C18H17FN8 | 1702271-98-4 | Details |
Riociguat Impurity 21/2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5,6-triamine | C17H15FN8 | 428854-24-4 | Details |
Riociguat Impurity 23/Methyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(ethyl)carbamate | C21H21FN8O2 | 1361570-27-5 | Details |
Riociguat Impurity 28/6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)- 7,9-dimethyl-7,9-dihydro-8H-purin-8-one | C20H17FN8O | 1361569-23-4 | Details |
Riociguat Impurity 31/1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid | C14H10FN3O2 | 956011-26-0 | Details |
Dabigatran Impurity 1/2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-N-(3-amino-3-oxopropyl)-1-methyl-N-2-pyridinyl-1H-benzimidazole-5-carboxamide | C25H26N8O2 | 1643377-48-3 | Details |
Dabigatran impurity 29/N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | C32H36N6O6 | 1408238-37-8 | Details |
Rebamipide Impurity 3/4-chloro-N-(2-(2-oxo-1,2-dihydroquinolin-4-yl)ethyl)benzamide | C18H15ClN2O2 | 100342-53-8 | Details |
Dabigatran impurity 28/Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate | C19H21N5O2 | 1408238-41-4 | Details |
Rosuvastatin Impurity 25/Rosuvastatin EP Impurity A Sodium Salt/S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin Sodium Salt | C25H34FN3NaO7S* | 1714147-50-8 | Details |
Agomelatine impurity 2/7-Desmethyl Agomelatine/N-(2-(7-hydroxynaphthalen-1-yl)ethyl)acetamide | C14H15NO2 | 152302-45-9 | Details |
Levetiracetam impurity 2/(S)-Levetiracetam EP Impurity A/Levetiracetam S-Carboxylic Acid/(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid | C8H13NO3 | 102849-49-0 | Details |
Donepezil impurity 21/5,6-Dimethoxy-2-[(4-piperidyl)methyl]indane Hydrochloride | C17H26ClNO2 | 1034439-43-4 | Details |
Donepezil impurity 13/Dihydro Donepezil Impurity/2-((1-benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-ol | C24H31NO3 | 120012-04-6 | Details |
Levetiracetam impurity 3/(R)-Levetiracetam EP Impurity A/Levetiracetam R-Carboxylic Acid/(R)-2-(2-oxopyrrolidin-1-yl)butanoic acid | C8H13NO3 | 103833-72-3 | Details |
Donepezil impurity 18/N-Debenzyl Donepezil/5,6-Dimethoxy-2-(piperidin-4-yl)methylindan-1-one | C17H23NO3 | 120014-30-4 | Details |
Levetiracetam impurity 5/Levetiracetam EP Impurity D/(R)-Etiracetam/Levetiracetam R-Isomer/(R)-2-(2-oxopyrrolidin-1- yl)butanamide | C8H14N2O2 | 103765-01-1 | Details |
Levetiracetam impurity 9/2-[(4-Ethoxy-4-oxobutyl)amino]butanoic acid | C10H19NO4 | 1342229-32-6 | Details |
Levetiracetam Impurity 24/Levetiracetam Racemate/Etiracetam/(R)-2-(2-oxopyrrolidin-1-yl)butanamide | C8H14N2O2 | 33996-58-6 | Details |
Levetiracetam impurity 7/2-[(4-Amino-4-oxobutyl)amino]butanamide | C8H17N3O2 | 1341459-52-6 | Details |
Rebamipide impurity 2/Rebamipide 3-Chloro Impurity/2-(3-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | C19H15ClN2O4 | 90098-05-8 | Details |
Rebamipide impurity 1/Rebamipide 2-Chloro Impurity/4-Deschloro-2-chlorobenzoyl Rebapimide/2-(2-Chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | C19H15ClN2O4 | 90098-06-9 | Details |
Lesinurad Impurity 11/2-[[5-Amino-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | C17H16N4O2S | 1158970-37-6 | Details |
Lesinurad Impurity 5/ 2-[[5-Bromo-4-(5-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid | C17H14BrN3O2S | 1533519-97-9 | Details |
Lesinurad Impurity 7/2-[[4-(4-Cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | C17H15N3O2S | 1533519-93-5 | Details |
Mirabegron impurity 1/(S)-Mirabegron/Mirabegron Enantiomer/(S)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl) amino)ethyl)phenyl)acetamide | C21H24N4O2S | 1796931-48-0 | Details |
Azilsartan impurity 25/Ethyl 2-ethoxy-3-[[4-[2-(N'-hydroxycarbamimidoyl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate | C26H26N4O4 | 1397836-41-7 | Details |
Lesinurad Impurity 4/ 2-[[5-Bromo-4-(4-propylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid | C17H16BrN3O2S | 1533519-96-8 | Details |
Lesinurad Impurity 1/2-[[5-Bromo-4-(naphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid | C14H10BrN3O2S | 1210330-64-5 | Details |
Lesinurad Impurity 2/2-((5-bromo-4-(4-methylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid | C15H12BrN3O2S | 1158970-49-0 | Details |
Levetiracetam impurity 1/Levetiracetam EP Impurity A/Levetiracetam Carboxylic Acid Racemate/(2RS)-2-(2-Oxopyrrolidin-1-yl)butanoic acid | C8H13NO3 | 67118-31-4 | Details |
Edoxaban impurity 3/N1-(5-chloropyridin-2-yl)-N2-((1S,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido) | C24H30ClN7O4S | 1255529-28-2 | Details |
Rebamipide Impurity 4/2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride | C12H13ClN2O3 | 4876-14-6 | Details |
Donepezil impurity 2/Donepezil N-Oxide/(RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1-indanone N-Oxide | C24H29NO4 | 120013-84-5 | Details |
Donepezil impurity 12/Deoxy Donepezil Hydrochloride/4-[(2,3-Dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine Hydrochloride | C24H32ClNO2 | 1034439-57-0 | Details |
Donepezil impurity 10/Dehydrodeoxy Donepezil Impurity/Donepezil Dehydro Deoxy Impurity/1-Benzyl-4-[(5,6-dimethoxyinden-2-yl)methyl] piperidine | C24H29NO2 | 120013-45-8 | Details |
Donepezil impurity 4/Donepezil Pyridine Analog Impurity/5,6-Dimethoxy-2-(pyridin-4-ylmethyl)indan-1-one | C17H17NO3 | 4803-57-0 | Details |
Donepezil impurity 7/Donepezil benzyl bromide impurity/1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxoindan-2-ylmethyl]piperidinium bromide | C31H36BrNO3 | 844694-85-5 | Details |
Levetiracetam impurity 6/4-[[1-(Aminocarbonyl)propyl]amino]butanoic acid | C8H16N2O3 | 1342566-28-2 | Details |
Levetiracetam impurity 4/Levetiracetam EP Impurity B/(Z)-2-(2-oxopyrrolidin-1-yl)but-2- enamide | C8H12N2O2 | 358629-47-7 | Details |
Levetiracetam impurity 8/2-[(3-Carboxypropyl)amino]butanoic acid | C8H15NO4 | 1543353-92-9 | Details |
Levetiracetam impurity 10/2-[(3-carboxypropyl)amino]-Butanoic acid 1-methyl ester | C9H17NO4 | 1543300-90-8 | Details |
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide | C10H11Cl2NO | 39084-88-3 | Details |
N-(2-Amino-4-thiazolyl)acetylMirabegron | C26H28N6O3S2 | 1684452-83-2 | Details |
Rabeprazole impurity 1/Rabeprazole EP Impurity A/Rabeprazole Sulfone/2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole | C18H21N3O4S | 117976-47-3 | Details |
Mirabegron impurity 2/Mirabegron Deshydroxy Impurity/2-(2-aminothiazol-4-yl)-N-(4-(2-(phenethylamino)ethyl)phenyl)acetamide | C21H24N4OS | 1581284-82-3 | Details |
Rabeprazole impurity 10/2-(chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine | C11H16ClNO2 | 117977-20-5 | Details |
Mirabegron impurity 6/2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid | C10H10N4O3S2 | 2036283-13-1 | Details |
Lesinurad Impurity 6/2-[[5-Bromo-4-(1-cyclopropylnaphthalen-2-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | C17H14BrN3O2S | 1533519-94-6 | Details |
Lesinurad Impurity 9/2-[[5-Chloro-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | C17H14ClN3O2S | 1533519-98-0 | Details |
Donepezil impurity 3/Donepezil Alkene Pyridine N-Oxide/Donepezil Pyridine Dehydro N-Oxide/(E)-4-[(5,6-Dimethoxy-1-oxo-1Hinden-2-yl)methyl]pyridine1-oxide | C17H15NO4 | 896134-06-8 | Details |
Donepezil impurity 1/Donepezil Related Compound A/Donepezil Dehydro Impurity/(2E)-Dehydro Donepezil/ (E)-2-[(1-Benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one | C24H27NO3 | 145546-80-1 | Details |
Donepezil impurity 11/Donepezil Deoxy Impurity/1-Benzyl-4-[(5,6-dimethoxyindan-2-yl)methyl] piperidine | C24H31NO2 | 844694-84-4 | Details |
Donepezil impurity 5/3-Hydroxy Donepezil/2-((1-Benzylpiperidin-4-yl)methyl)-3-hydroxy-5,6-dimethoxy-2,3-dihydroinden-1-one | C24H29NO4 | 2097683-67-3 | Details |
Donepezil impurity 8/6-O-Desmethyl Donepezil/1-benzyl-4-(6-hydroxy,5-methoxy-1-indanone-2-yl)methyl piperadine | C23H27NO3 | 120013-56-1 | Details |
Edoxaban impurity 15/tert-Butyl ((1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl)carbamate | C14H26N2O4 | 929693-30-1 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |